Global Codeine Narcotic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Codeine Narcotic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Codeine Narcotic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Codeine Narcotic market is projected to reach US$ 965 million in 2029, increasing from US$ 681.5 million in 2022, with the CAGR of 5.1% during the period of 2024 to 2029. Demand from Narcotic Analgesic and Antitussive are the major drivers for the industry.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Codeine Narcotic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Narcotic Analgesic
Antitussive
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Codeine Narcotic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Codeine Narcotic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Codeine Narcotic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Codeine Narcotic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Codeine Narcotic introduction, etc. Codeine Narcotic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Codeine Narcotic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Codeine Narcotic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Codeine Narcotic market is projected to reach US$ 965 million in 2029, increasing from US$ 681.5 million in 2022, with the CAGR of 5.1% during the period of 2024 to 2029. Demand from Narcotic Analgesic and Antitussive are the major drivers for the industry.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Codeine Narcotic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Codeine Narcotic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Codeine Narcotic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Codeine Narcotic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Codeine Narcotic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Codeine Narcotic introduction, etc. Codeine Narcotic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Codeine Narcotic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices